Knobbe Martens opens New York office
Ahead of his participation in an LSPN Connect session, Trade Secrets: An Alternative for Life Sciences IP? on Thursday, October 8, Mike Fuller, managing partner at Knobbe Martens, shares some insights about the challenges facing life sciences IP and why innovations are ripe for trade secret protection.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at email@example.com
LSPN Connect, life sciences, Knobbe Martens, Mike Fuller, trade secrets, IP, COVID-19, artificial intelligence